[Skip to Navigation]
Observation
November 25, 2020

Treatment of Xanthoma Disseminatum With Narrowband UV-B Phototherapy

Author Affiliations
  • 1Department of Dermatology, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
JAMA Dermatol. 2021;157(2):235-237. doi:10.1001/jamadermatol.2020.4092

Xanthoma disseminatum (XD) is a rare non-Langerhans cell histiocytosis that is characterized by the proliferation of histiocytic cells and secondary deposition of lipids in the dermis, which can affect people at any age. Men are more commonly affected than women.1 Treating XD is challenging. We present a patient with XD with marked facial involvement who was successfully treated with narrowband UV-B (NB–UV-B) phototherapy.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×